Gonorrhea's own enzyme triggers therapy against multidrug-resistant strains in lab tests
Scientists at the Universities of Liverpool and Oxford have developed a promising new way to kill antibiotic-resistant strains of Neisseria gonorrhoeae, the bacterium that causes gonorrhea, using a targeted therapy that is activated at the bacterial surface while minimizing damag
Scientists at the Universities of Liverpool and Oxford have developed a promising new way to kill antibiotic-resistant strains of Neisseria gonorrhoeae, the bacterium that causes gonorrhea, using a targeted therapy that is activated at the bacterial surface while minimizing damag This story matters for Science & Discovery readers tracking certification. Reported by phys.org. Read the full original at the source link below.
Originally reported by phys.org. CertificationNews curates and briefs the science & discovery stories that matter. Our editorial policy →